Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Care Publish Ahead of Print published online ahead of print March 10, 2008
DOI: 10.2337/dc07-1810

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc07-1810v1
31/6/1248    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taylor, H.
Right arrow Articles by Sung, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, H.
Right arrow Articles by Sung, J. H.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Distinct Component Profiles and High Risk among African Americans with the Metabolic Syndrome: The Jackson Heart Study

Herman Taylor, M.D., MPH., Jiankang Liu, M.D., Ph.D., Gregory Wilson, MS, Sherita H. Golden, M.D., M.H.S., Errol Crook, M.D., Ph.D., Claude D. Brunson, M.D., Micheal Steffes, M.D., William D. Johnson, Ph.D. and Jung Hye Sung, Sc.D., MPH.

1Jackson Heart Study, Jackson State University, University of Mississippi Medical Center, Jackson, Mississippi 39216-4505, USA

htaylor{at}medicine.umsmed.edu

ABSTRACT

Objective: African American (AA) health is seriously threatened by unremitting epidemics of diabetes and cardiovascular disease (CVD). However, the role of metabolic syndrome (MetS) in the AA population has not been investigated widely. This study examined the prevalence of MetS and assessed its cross-sectional relationship to CVD in Jackson Heart Study (JHS) cohort.

Research Design and Methods: 5302 participants aged ≥ 21 years who recruited in the baseline during 2000-2004 were analyzed for this study. Adjusted odds ratios (OR) were estimated in a logistic regression analysis for coronary heart disease (CHD) and cerebrovascular disease (CBD) in those with and without co-existing MetS. Diabetic participants were excluded.

Results: Among ages 35-84, MetS prevalence was 43.3% in women and 32.7% in men. Elevated blood pressure (70.4%), abdominal obesity (64.6%), and low HDL-C (37.2%) were highly prevalent among those with MetS. Prevalence rates for CVD, CHD and CBD were 12.8%, 8.7%, and 5.8%, respectively. After adjustment for age and sex, MetS was associated with increased age- and sex-adjusted OR for CVD (OR = 1.7; 95% CI 1.4-2.1), CHD (1.7; CI 1.4-2.2) and CBD (1.7; CI 1.3-2.3), compared to those without CVD, CHD or CBD.

Conclusion: MetS prevalence in the JHS is among the highest reported for population-based cohorts worldwide and significantly associated with increased OR for CVD, CHD and CBD. Abdominal obesity, increased blood pressure and low HDL-C (without triglyceride elevation) are surprisingly prominent. High prevalence of low HDL emerges as a leading contributor to MetS among AA in this large AA cohort.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.